Max Robotics — Global Service Robot Directory + US Certification

About

Angeliki Chalkiadaki is a pioneering researcher in the field of organ-on-a-chip technology, with a focus on creating integrated, automated platforms that mimic human physiology for drug testing. Her major contributions center on the development of fluidically coupled, vascularized organ chips and robotic systems that enable high-throughput, multi-organ experimentation. Her most-cited work, "Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips" (2020, 463 citations), demonstrates how these chips can accurately forecast human drug responses, bridging the gap between preclinical models and clinical outcomes. She also co-authored "Robotic fluidic coupling and interrogation of multiple vascularized organ chips" (2020, 401 citations), which advances automated interrogation of interconnected chips. Her foundational paper, "A robotic platform for fluidically-linked human body-on-chips experimentation" (2019), introduces the ‘Interrogator’ instrument—a robotic system that automates culture, perfusion, and imaging of up to 10 Organ Chips, revolutionizing scalability in drug development. Chalkiadaki’s work is transformative for personalized medicine and toxicology, offering a powerful alternative to animal testing. Her innovations have garnered widespread recognition, positioning her as a leader in synthetic human biology.